Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Publikationen Univ.-Prof. Dr. Halina Baran Publications of original research 1. G. Sperk, H. Lassmann, H. Baran, J. Kish, F. Seitelberger and O. Hornykiewicz (1983) Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience, 10, 1301-1315. 2. H. Lassmann, U. Petsche, K. Kitz, H. Baran, G. Sperk, F. Seitelberger and O. Hornykiewicz (1984) The role of brain edema in epileptic brain damage induced by systemic kainic acid injection. Neuroscience, 13, 691-704. 3. H. Baran, G. Sperk, H. Hörtnagl, G. Sapetschnig and O. Hornykiewicz (1985) 2Adrenoceptors modulate kainic acid-induced limbic seizures. Eur. J. Pharmacol, 113, 263-269. 4. G. Sperk, H. Lassmann, H. Baran, F. Seitelberger and O. Hornykiewicz (1985) Kainic acid-induced seizures: Dose-relationship of behavioural, neurochemical and histopathological changes. Brain Res., 338, 289-295. 5. H. Baran, R. Heldt and G. Hertting (1987) Increased prostaglandin formation in rat brain following systemic application of kainic acid. Brain Res., 404, 107-112. 6. H. Baran, G. Lassmann, G. Sperk, F. Seitelberger and O. Hornykiewicz (1987) Effect of mannitol treatment on brain neurotransmitter markers in kainic acid-induced epilepsy. Neuroscience, 21, 679-684. 7. H. Baran, H. Hörtnagl and O. Hornykiewicz (1989) Kainic acid-induced seizures: potentiation by -methyl -p-tyrosine. Brain Res., 495, 253-260. 8. H. Baran and R. Schwarcz (1990) Presence of 3-hydroxyanthranilic acid in rat tissue and evidence for its production from anthranilic acid in the brain. J. Neurochem., 55, 738-744. 9. H. Baran and K. Jellinger (1992) Human brain phenolsulphotransferase. Regional distribution in Parkin-son's Disease. J. Neural. Transm., 4, 267-276. 10. H.-Q Wu, H. Baran, U. Ungerstedt and R. Schwarcz (1992) Kynurenic acid in the quinolinate-lesioned rat hippocampus: Studies in vitro and in vivo. Eur. J. Neurosci., 4, 1264-1270. 11. H. Baran and R. Schwarcz (1993) Regional differences in the ontogenetic pattern of kynurenine amino-transferase in the rat brain. Develop. Brain. Res., 74, 283-286. 12. O.G. McMaster, H. Baran, H.-Q. Wu, F. Du, E. French and R. Schwarcz (1993) Acetylenic GABA produces axon-sparing neurodegeneration after focal injection into the rat hippocampus. Exp. Neurol., 124, 184-191. 13. H. Baran, E. Okuno, R. Kido and R. Schwarcz (1994) Purification and characterization of kynurenine aminotransferase I from human brain. J. Neurochem., 62, 730-738. 14. W. Löscher, P. Wlaz, Ch. Rundfelt, H. Baran and D. Hönack (1994) Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)HA-966 in amygdala-kindled rats. Brit. J. Pharmacol., 112, 97-106. 15. P. Wlaz, H. Baran and W. Löscher (1994) Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK801 in mice. Eur. J. Pharmacol., 257, 217-225. 16. H. Baran, W. Löscher, M. Mevissen (1994) The glycine/NMDA receptor partial agonist Dcycloserine blocks kainate-induced seizures in rats. Comparison with MK-801 and diazepam. Brain Res., 652, 195-200. 17. H. Baran, K. Vass, H. Lassmann, O. Hornykiewicz (1994) The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid-induced seizures and neurotoxicity. Brain Res., 646, 201-206. 18. H. Baran, M. Gramer and W. Löscher (1995) Alterations in plasma and brain amino acids after admini-stration of the glycine/NMDA receptor partial agonist D-cycloserine in mice and rats. Eur. J. Pharmacol., 273, 197-201. 19. H. Baran, M. Gramer, D. Hönack and W. Löscher (1995) Systemic administration of kainate induces marked increase of endogenous kynurenic acid in various brain regions and plasma of rats. Eur. J. Pharmacol., 286, 167-175. 20. R. Seidl, S. Beninati, N. Cairs, N. Singewald, D. Risser, H. Baran, M. Nemethova, G. Lubec (1996) Polyamines in frontal cortex of patients with Down syndrome and Alzheimer disease. Neurosci. Lett., 206, 1-3. 21. H. Baran, N. Cairns, B. Lubec and G. Lubec (1996) Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with DOWN syndrome. Life Sci. 58, 21, 1891-1899. 22. Richter, W. Löscher, H. Baran and M. Gramer (1996) Increased levels of kynurenic acid in brains of genetically dystonic hamster. Dev. Brain Res., 92, 111-116. 23. H. Baran, G. Amann, B. Lubec and G. Lubec (1997) Kynurenic acid and kynurenine aminotransferase in heart. Pediatr. Res., 41, 3, 404-410. 24. H. Baran, K. Jellinger and L. Deecke (1999) Kynurenine metabolism in Alzheimer’s disease. J. Neural. Transm.,106: 165-181. 25. T. Möslinger, Friedl R., Volf I, Brunner M., Baran H., Koller E. and P.G. Spieckermann (1999) Urea induces macrophage proliferation by inhibition of inducible nitric oxide synthesis. Kidney-International, 56, 2, 581-588. 26. S. Schuller, N. Patel, C. Item, S. Greber-Platzer, H. Baran, W. Patsch and W. Strobl (2000) The genetic background modifies the effects of the leptin receptor mutation, fatty, on apolipoprotein gene regulation in rat liver. Int. J. Obes. Relat. Metab. Disord., 24, 460-467. 27. H. Baran, B. Kepplinger and H. Hörtnagl (2000) Clonidine modulates the BAY K 8644 induced behavior and neurotransmitter changes in the rat brain. Eur. J. Pharmacol., 401, 1, 31-37. 2 28. H. Baran, J.A. Hainfellner, B. Kepplinger. P.R. Mazal, H. Schmid und H. Budka (2000) Kynurenic acid metabolism in the brain of HIV-1 infected patients. J. Neural. Transm., 107, 1127-1138. 29. H. Baran, K. Staniek, B. Kepplinger L. Gille and H. Nohl (2001) Influence of kynurenines on respiratory activities of rats heart mitochondria. Pharmacology, 62, 119-123. 30. H. Baran, B. Kepplinger, M. Herrera-Marschitz, K. Stolze, G. Lubec and H. Nohl (2001) Increased kynurenic acid in the brain after neonatal asphyxia, Life Sciences 69, 12491256. 31. H. Baran, K. Staniek, B. Kepplinger, I. Stur, M. Draxler and H. Nohl (2003) Kynurenines and the respiratory parameters in rat heart mitochondria. Life Sciences 72, 1103-1115. 32. H. Baran, B. Kepplinger, M. Draxler, G. Skofistch (2004) Choline acetyltransferase, glutamic acid decarboxylase and somatosatin in the kainic acid model for chronic temporal lobe epilepsy. Neurosignals, 13, 290-297. 33. B. Kepplinger, H. Baran, A. Kainz, H. Ferraz-Leite, J. Newcombe and P. Kalina (2005) Age-related increase of kynurenic acid in human cerebrospinal fluid: Positive correlation with IgG and ß2-microglobulin changes. Neurosignals, 14(3), 126-135. 3 Book contributions 1. H. Lassmann, H. Baran, U. Petsche, K. Kitz, G. Sperk, O. Hornykiewicz and F. Seitelberger (1986) Ultrastructural analysis of rat brain tissue following systemic kainate administration. Adv. Exp. Med. Biol., 203, 223-230. 2. H. Baran and R. Schwarcz (1989) Measurement of 3-hydroxyanthranilic acid and its synthesis rate in brain by high-performance liquid chromatography with electrochemical detection Adv. Exp. Med. Biol., 249, 485-488. 3. R. Schwarcz, H. Baran, H.-Q. Wu, F. Du and O. McMaster (1991) The neurochemistry of quinolinate and kynurenate: Current concepts. In: "Excitatory Amino Acids" (B.S. Meldrum, F. Moroni, R.P. Simon and J.H. Woods, eds.) Raven Press, New York, pp. 365375. 4. H. Baran, M. Gramer, D. Hönack and W. Löscher (1995) Systemic administration of kainate induces marked increase of endogenous kynurenic acid in various brain regions and plasma of rats. Adv. Exp. Med. Biol., 398, 265-266. 5. M. Draxler H. Baran, F. Schmoll, N. Nowotny, B. Kepplinger, A. Url, P. Schmidt, A. Strasser, H. Niedermüller, G. Hofecker and M. Schuh (2004) Affected choline acetyltransferase (ChAT) activity in piglet brain after encephalomyocarditis (EMCV) virus infection. IPVS 2004, 18th Congress of the International Pig Veterinary Society International Proceedings. 6. M. Draxler, B. Kepplinger, F. Schmoll, N. Nowotny, A. Url, P. Schmidt, A. Strasser, H. Niedermüller, M. Schuh and H. Baran (2004) Choline acetyl transferase (ChAT) and glutamic acid decarboxylase (GAD) activities in control piglet brain. IPVS 2004, 18th Congress of the International Pig Veterinary Society International Proceedings. 7. H. Baran, B. Kepplinger, Ch. Lang, M. Draxler, F. Schmoll, A. Strasser, M. Schuh and N. Nowotny (2004) Enhancement of Kynurenic acid (KYNA) and neopterin levels in serum of piglets after encephalomyocarditis virus (EMCV) infection. IPVS 2004, 18th Congress of the International Pig Veterinary Society International Proceedings. 8. H. Baran, B. Kepplinger, M. Draxler and H. Ferraz-Leite (2004) Kynurenic acid metabolism in rat, piglet and human tissues. In European Society for Clinical Neuropharmacology by ed L. Battistin, International Proceedings MEDIMOND S.r.1. E505R9004, 227-231. 9. B. Kepplinger, M. Draxler and H. Ferraz-Leite, J. Wallner, H Schmid and H. Baran, (2004) KCN influences kynurenine aminotransferase I and II activities in an In Vitro Study. In European Society for Clinical Neuropharmacology by ed L. Battistin, International Proceedings MEDIMOND S.r.1. E505R9004, 233-236. 4 Supplements/Abstracts (published) 1. H. Baran, G. Sperk, H. Hörtnagl and O. Hornykiewicz (1982) Inhibition of kainic acid induced convulsions by clonidine in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. Suppl. 321, R.43. 2. H. Baran and H. Lassmann (1987) Influence of inhibition of arachidonic acid metabolism in kainic acid induced epilepsy. Naunyn-Schmiedeberg's Arch. Pharmacol. Suppl. 335, 166. 3. H. Baran, H. Hörtnagl and O. Hornykiewicz (1987) Kanic acid-induced seizures in rat: potentiation by alpha-methyl-p-tyrosine and therapeutic efficiency of clonidine. Neuroscience, Suppl. to Vol. 22. 4. H. Baran, H. Lassmann and O. Hornykiewicz (1988) Behavior and neurochemical changes 6 months after kainic acid. Soc. Neurosci, 14, 593.7. 5. H. Baran and R. Schwarcz (1989) Preferential production of 3-hydroxyanthranilic acid from anthranilic acid in rat brain slices. Soc. Neurosci. Abstr. 15, 328.5. 6. R. Schwarcz, H. Baran and E. Okuno (1989) Anthranilate hydroxylase in rat brain. Soc. Neurosci. Abstr. 15, 328.6. 7. H. Baran and R. Schwarcz (1990) Pyrazinamide stimulates 3-hydroxyanthra-nilate production from anthranilate in rat brain and spleen slices. Soc. Neurosci. Abstr. 16, 200.12. 8. H. Baran, E. Okuno, R. Schwarcz and R. Kido (1991) Purification and characterization of kynurenine aminotransferase I from human brain. Japanese Biochemical Society 1926, Congress, Tokyo, Japan Abstr. 63, 8. 9. M. Susol, H. Baran, H.-Q. Wu and R. Schwarcz (1991) Effect of development and chronic neuroleptic treatment on kynurenic acid synthesis in the rat brain. Soc. Neurosci. Abstr. 17, 106.9. 10. H. Baran, F. Du and R. Schwarcz (1991) Transient increase in striatal kynurenate synthesis following systemic kainate administration in rat. Soc. Neurosci. Abstr. 17, 356.10. 11. H.-Q. Wu, H. Baran, F. Du and R. Schwarcz (1991) Kynurenic acid production in the rat hippocampus: Effects of quinolinate lesion. Soc. Neurosci. Abstr. 17, 356.8. 12. H. Baran, E. Okuno, R. Kido and R. Schwarcz (1992) Human brain kynurenine aminotransferase I: Purification and characteristic. Soc. Neurosci. Abstr. 18, 581.1 13. O.G. McMaster, H. Baran, F. Du, H.-Q. Wu, E.D. French and R. Schwarcz (1992) Gamma-acetylenic GABA causes excitotoxic lesions in the rat hippocampus. Soc. Neurosci. Abstr. 18, 190,11. 14. E. Okuno, M. Nakamura, H. Baran, R. Schwarcz and R. Kido (1993) Human kynurenine aminotransferase II: Purification from liver and comparison with the brain enzyme. Soc. Neurosci. Abstr. 19, 567.11. 5 15. H. Baran, R. Schwarcz (1993) Limbic seizures cause increase in kynurenic acid neosynthesis and attenuation of valuerability to excitotoxins in the rat striatum. Soc. Neurosci. Abstr. 19, 554.8. 16. E. Schuller, N. Patel, Ch. Item, H. Baran, W. Patsch, W. Strobel (1997) The effect of the obesity mutation fatty on hepatic apolipoprotein gene expression in rats is modified by the genetic backgrounds. Atherosclerosis, Vol.130, Suppl. S1-S40, 138. 17. H. Baran and K. Jellinger (1998) Kynurenine metabolism in Alzheimer disease brain. Eur. J. of Neuroscience, Vol. 10, Suppl. 10, 32.09. 18. H. Baran, K. Staniek, L. Gille, K. Stolze and H. Nohl (1999) Influence of kynurenine’s on respiratory control parameters of rat heart mitochondria. Pharmacology, Abst, 55,321328. 19. H. Baran, K. Staniek, L. Gille, K. Stolze and H. Nohl (2000) Influence of kynurenines on respiratory control parameters of rat heart mitochondria. Naunyn-Schmiedeberg's Archives of Pharmacology Suppl. to Vol. 361, Nr 4, R11, 32. 20. H. Baran, B. Kepplinger, K. Staniek, K. Stolze, L. Gille and H. Nohl (2000) Non-specific aminotransferase inhibitors influence differently the respiratory control parameters of rat heart mitochondria. Pharmacology, Abstracts 61:269-279. 21. H. Baran, B. Kepplinger, J. Newcombe, K. Stolze, A. Kainz and H. Nohl (2000) Lowered kynurenine aminotransferase activities in CNS of MS patients. Soc. Neurosci. Abstr. 26, 481.12. 22. H. Baran (2001) Differential susceptibility of Neurochemical markers upon kainate induced epilepsy and its significances Polish J. of Neurology, Suppl. to Vol. 28 23. H. Baran, B. Kepplinger, C. Derfler, A. Kainz, J. Newcombe and H. Nohl (2001) Kynurenic acid in CSF and serum of subcortical sclerotic encephalopathy. Soc. for Neurosci. Abstr. 24. B. Kepplinger, H. Baran, H. Schmid, J Wallner, J. Newcombe, and H. Nohl H. (2001) Increased kynurenic acid levels in the CNS of patients suffering from polyneuropathy and neuroborreliosis. Soc. Neurosci. Abstr. 25. B. Kepplinger, D. Schafelner, Ch. Derfler, H. Ferraz-Leite and H. Baran (2002) CTUnterstützte diagnostische Lokalanästhesie-Blockade, Der Schmerz 4, 16, 326. 26. H. Baran, B. Kepplinger, J.A. Heinfelner, G. Lubec and H. Budka (2002) Kynurenic acid metabolism in different types of brain pathology in HIV-1 infected patients. Eur. J. of Neurology, Vol 9, Suppl. 2, pp 16, Sc 115. 27. H. Baran, B. Kepplinger, G. Skofitsch, H. Lassmann (2002) Malignant glioma within the temporal lobe in the rat brain after kainic acid induced chronic epilepsy - Single case. Eur. J. of Neurology, Vol 9, Suppl. 2, pp 175, P 3040. 28. H. Baran, B. Kepplinger, A. Kainz, M. Draxler, H. Ferraz-Leite, J. Wallner, J. Newcombe, and H. Erhart (2003) Kynurenine aminotransferases in human cerebrospinal fluid. J. of Neurology, Vol 250, Suppl. 2, pp II10, 4. 29. B. Kepplinger, H. Baran, A. Kainz, H. Schmid, J. Wallner, M. Draxler, H. Ferraz-Leite and J. Wallner (2003) Increased kynurenic acid and IgG in cerebrospinal fluid of patients with polyneuropathy. J. of Neurology, Vol 250, Suppl. 2, pp II/160-II/161, P 611. 6 30. B. Kepplinger, D. Schafelner, H. Baran and P. Kalina (2003) Nerve root stimulation as a novel alternative to spinal cord stimulation in the treatment of chronic radicular pain in human. Soc. Neurosci. Abstr. 33. 437.10. 31. H. Baran, M. Draxler, H. Kalbacher, N. Nowotny, P. Schmidt, B. Kepplinger, A. Url, M. Schuh, G. Hofecker. (2003) Kynurenine aminotransferase I and II (KAT I and KAT II) in piglet’s brain after Encephalomyocarditis (EMCV) infection. Soc. Neurosci. Abstr 33. 215.8. 32. H. Baran, M. Draxler, B. Kepplinger, H. Kahlbacher, N. Nowotny, P. Schmidt, A. Url, M. Schuh and G. Hofecker (2003) Kynurenine metabolism in piglet brain due to EMCV infection. Pharmacology 69, 212-217:1, DOI: 10.1159/000073666. 33. B. Kepplinger, H. Baran, H. Papst, H. Ferraz-leite, J. Walner, H. Schmid (2004) Kynurenate and its analogues: a new route for therapeutic applications in neuropsychiatry. J. Neural Transm. Vol. 111, No 5, XXXI, 95. 34. H. Baran (2004) Kynurenic acid metabolism – pharmacological and clinical aspects. J. Neural Transm. Vol. 111, No 5, XV, 43. 35. Baran, M. Draxler, B. Kepplinger and H. Niedermüller (2004) Reduced glutamic acid decarboxylase (GAD) brain regions of piglets in experimental encephalomyocarditis (EMCV) model. J. Neurology Vol 11, Supplement 2, P2548, pp 322-323. 36. B. Kepplinger, M. Draxler, A. Strasser and H. Baran (2004) Choline acetyltransferase activity in the spinal cord after experimental encephalomyocarditis virus (EMCV) infection. J. Neurology Vol 11, Supplement 2, P2547, pp 322. 37. H. Baran (2005) Alterations of taurine in the brain of chronic kainic acid epilepsy model. Amino Acids Abstracts, Vol. 29, No. 1, Neurobiology, pp. 22. 38. H. Baran, B Kepplinger (2005) Glycine in the brain of chronic kainic acid epilepsy model. Euro. J. of Neurology , Vol 12, Suppl. 2, pp 239, P 2300. 7 Popular medical reports 1. H. Baran (2003) Qualitätsmanagement und seeliche Gesundheit. KlinikForum 4, 8 12. 2. H. Baran (2003) Gesundheit und Qualitätsmanagement. Consilium 4, 27- 28. 3. H. Baran (2004) Schlaganfall - Symposium im Klinikum Mostviertel. KlinikForum 5, 5. 4. B. Kepplinger and H. Baran (2005) Propriozeptives Training (Zeptoring) bei chronischem Schmerz und Depression. Physikalische Medizin und Rehabilitation, Adjutum Verlag, 2. Quartal, pp.15. 8 Lecture or Posters presentations 1. F. Seitelberger, H. Lassmann, K. Kitz, U. Petsche, H. Baran and O. Hornykiewicz (1983) Systemic administration of kainic acid: an experimental model of cytotoxic brain edema in epileptic seizures. Annual Meeting of Amer. Ass. Neuropathologists, San Diego, CA, U.S.A. (Lecture) 2. M.L. Berger, H. Hörtnagl, H. Baran and O. Hornykiewicz (1985) Clonidine attenuates limbic seizures induced by intraamygdaloid kainic acid injection. Symposium "Neuroscience in Austria", Vienna, Austria. (Poster) 3. H. Baran, R. Heldt and G. Hertting (1986) Increased prostaglandin formation in rat brain following systemic application of kainic acid. 6 Int. Conf. on Prostagl. and Relat. Comp. Florence, Italy. (Poster) 4. H. Baran, H. Hörtnagl and O. Hornykiewicz (1987) Kanic acid-induced seizures in rat: potentiation by alpha-methyl-p-tyrosine and therapeutic efficiency of clonidine. Second World Congress of Neuroscience, Budapest. (Poster) 5. H. Baran, H. Lassmann and O. Hornykiewicz (1988) Behavior and neurochemical changes 6 months after kainic acid. Soc. Neurosci, 14, 593.7. (Lecture) 6. H. Baran and R. Schwarcz (1989) Measurement of 3-hydroxyanthranilic acid and its synthesis rate in brain by high-performance liquid chromatography with electrochemical detection. ISTRY Meeting, Baltimore, MD. (Poster) 7. H. Baran and R. Schwarcz (1989) Preferential production of 3-hydroxyanthranilic acid from anthranilic acid in rat brain slices. Soc. Neurosci. Abstr. 15, 328.5. (Lecture) 8. H. Baran and R. Schwarcz (1989) Production of 3-hydroxyanthranilic acid in rat brain and spleen. Therapy with amino acids and analogues. 1st International Congress, Vienna, Austria. (Lecture) 9. R. Schwarcz, H. Baran and E. Okuno (1989) Anthranilate hydroxylase in rat brain. Soc. Neurosci. Abstr. 15, 328.6. (Lecture) 10. H. Baran and R. Schwarcz (1990) Pyrazinamide stimulates 3-hydroxyanthra-nilate production from anthranilate in rat brain and spleen slices. Soc. Neurosci. Abstr. 16, 200.12. (Lecture) 11. H. Baran, E. Okuno, R. Schwarcz and R. Kido (1991) Purification and characterization of kynurenine aminotransferase I from human brain. Japanese Biochemical Society 1926, Congress, Tokyo, Japan Abstr. 63, 8. (Lecture) 12. M. Susol, H. Baran, H.-Q. Wu and R. Schwarcz (1991) Effect of development and chronic neuroleptic treatment on kynurenic acid synthesis in the rat brain. Soc. Neurosci. Abstr. 17, 106.9. (Poster) 13. H. Baran, F. Du and R. Schwarcz (1991) Transient increase in striatal kynurenate synthesis following systemic kainate administration in rat. Soc. Neurosci. Abstr. 17, 356.10. (Lecture) 14. H.-Q. Wu, H. Baran, F. Du and R. Schwarcz (1991) Kynurenic acid production in the rat hippocampus: Effects of quinolinate lesion. Soc. Neurosci. Abstr. 17, 356.8. (Poster) 9 15. H. Baran, E. Okuno, R. Kido and R. Schwarcz (1992) Human brain kynurenine aminotransferase I: Purification and characteristic. Soc. Neurosci. Abstr. 18, 581.1 (Poster) 16. O.G. McMaster, H. Baran, F. Du, H.-Q. Wu, E.D. French and R. Schwarcz (1992) Gamma-acetylenic GABA causes excitotoxic lesions in the rat hippocampus. Soc. Neurosci. Abstr. 18, 190,11. (Lecture) 17. E. Okuno, M. Nakamura, H. Baran, R. Schwarcz and R. Kido (1993) Human kynurenine aminotransferase II: Purification from liver and comparison with the brain enzyme. Soc. Neurosci. Abstr. 19, 567.11. (Poster) 18. H. Baran, R. Schwarcz (1993) Limbic seizures cause increase in kynurenic acid neosynthesis and attenuation of valuerability to excitotoxins in the rat striatum. Soc. Neurosci. Abstr. 19, 554.8. (Lecture) 19. W. Löscher, P. Wlaz, Ch. Rundfelt, H. Baran, and D. Hönack (1994) The glycine/NMDA receptor ligands D-cycloserine and D-serine but not R+(-)-HA-966 exert anticonvulsant effects in amygdala-kindled rats. DGPT, Abstracts. (Lecture) 20. H. Baran and H. Hörtnagl (1994) Clonidine attenuate BAY k 8644 induced behavioural changes and neurochemical alterations in the brain. 17 Eur. Neurosci. Assoc. Abstr. 85.11. (Poster) 21. H. Baran (1994) Changes of dopaminergic neurotransmission after kainic acid-induced behavioural alteration. Soc. Neurosci. Abs. 20, 593.7. 22. H. Baran, M. Gramer, D. Hönack and W. Löscher (1995) Systemic administration of kainate induces marked increase of endogenous kynurenic acid in various brain regions and plasma of rats. ISTRY Meeting, Padova, Italy. (Poster) 23. Richter, W. Löscher, M. Gramer and H. Baran (1995) Increased levels of kynurenic acid in brains of genetically dystonic hamsters. Soc. Neurosci. Abstr. 21, 387.10. (Poster) 24. H. Baran, N. Cairns, N. Singewald and G. Lubec (1995) Kynurenic acid and kynurenine aminotransferases KAT I and KAT II in the brains of patients with DOWN syndrome and Alzheimer’s disease. Soc.Neurosci. Abstr. 21, 581.5. (Poster) 25. H. Baran, H. Budka, J.A. Hainfellner and G. Lubec (1996) Impairment of kynurenine metabolism in brains of patients with HIV infection. Neurosci. of HIV Infection, Abs., Paris, France. (Lecture) 26. H. Baran, J.A. Hainfellner, G. Lubec and H. Budka (1996) Kynurenine metabolism of patients with HIV infection: Impairment in frontal cortex but not in cerebellum. First Eur. Conf. on Exp. AIDS Res., Abs.,Cannes, France. (Lecture) 27. H. Baran and K. Jellinger (1997) Does increased kynurenic acid levels in the brain contribute to the impairement of memory in Alzheimer’s disease?. Second International Oxidative Stress and Brain Damage Symposium, Abs., Chicago, Illinois, USA. (Lecture) 28. H. Baran and L. Deecke (1997) Kynurenine Metabolism: A preliminary study in Multiple Sclerosis. Austrian Neurosci. Assoc. Abs., Pernegg/Geras, (NÖ), Austria. (Poster) 29. E. Schuller, N. Patel, Ch. Item, H. Baran, W. Patsch, W. Strobel (1997) The effect of the obesity mutation fatty on hepatic apolipoprotein gene expression in rats is modified by the genetic backgrounds. Atherosclerosis Kongress, Vienna, Austria. (Poster) 10 30. H. Baran and K. Jellinger (1998) Kynurenine metabolism in Alzheimer disease brain. Eur. Neuroscience Kongress, Berlin. Germany. 31. H. Baran, K. Staniek, L. Gille, K. Stolze and H. Nohl (1999) Influence of kynurenine’s on respiratory control parameters of rat heart mitochondria. APHAR, 24.-25. 11. 1999, Wien, Austria. (Lecture) 32. H. Baran, J.A. Hainfellner, B. Keppliger, P.R. Mazal, H. Schmid and H. Budka (1999) Kynurenic acid metabolism in the brain of HIV-1 infected patients: increased kynurenine aminotransferase I. X.Österreichischer AIDS-KONGRESS, 12-13 November, Wien. (Lecture) 33. H. Baran, K. Staniek, L. Gille, K. Stolze and H. Nohl (2000) Influence of kynurenines on respiratory control parameters of rat heart mitochondria. Pharmacology Kongress, Mainz, Germany. (Lecture) 34. Kepplinger, H. Baran and H. Hörtnagl (2000) Low dose of Ca++ antagonist BAY K 8644 augments kainic acid induced neurotoxicity in rat amygdala and piriform cortex. 32dnDanube Symposium on Neurological Sciences & Continuing Education, Baja, Hungary. (Poster) 35. H. Baran, B. Kepplinger, M. Herrera-Marschitz, G. Lubec, K. Stolze and H. Nohl (2000) Increased Kynurenic Acid in the Rat Brain after Neonatal Asphyxia. 32dnDanube Symposium on Neurological Sciences & Continuing Education, Baja, Hungary. 36. H. Baran, B. Kepplinger, J. Newcombe, K. Stolze, A. Kainz and H. Nohl (2000) Lowered kynurenine aminotransferase activities in CNS of MS patients. Soc. Neurosci. Abstr. 26, 481.12. (Poster) 37. H. Baran, J.A. Hainfellner, B. Kepplinger, P. Kalina and H. Budka (2000) HIV-1 infected patients show increased kynurenic acid metabolism in the brain. XI. Österreichischer AIDS-KONGRESS, 10-11 November, Innsbruck Österreich. (Lecture) 38. H. Baran, B. Kepplinger, K. Staniek, K. Stolze, L. Gille and H. Nohl (2000) Non-specific aminotransferase inhibitors influence differently the respiratory control parameters of rat heart mitochondria. APHAR, 24.-25. 11. 2000, Wien. (Lecture) 39. Kepplinger, H. Baran, J.A. Hainfellner, P. Kalina and H. Budka (2000) Kynurenic acid metabolism in different types of brain pathology in HIV-1 infected patients. 2nd International Meeting on Oxidative Stress. Biochemistry and Pathophysiology, Nov. 30Dec. 2, 2000. (Lecture) 40. H. Baran, K. Staniek, B. Kepplinger, and H. Nohl (2000) Tryptophan metabolites and respiratory control parameters of rat heart mitochondria. 2nd International Meeting on Oxidative Stress. Biochemistry and Pathophysiology, Nov. 30-Dec., Valencia, Spain. (Lecture). 41. H. Baran, B. Kepplinger, M. Herrera-Marschitz, and H. Nohl (2001) Asphyxia causes changes of kynurenic acid levels in the brain - an experimental study. ANIM 2001, Abstr. Nr. 81, Innsbruck, Austria. (Poster) 42. H. Baran, B. Kepplinger and H. Hörtnagl (2001) Ca2+ channels activator augments neurotoxicity in the animals model for temporal lobe epilepsy. Neurochemistry Winter Conference March 17-22, 2001, Sölden, Austria. (Poster) 11 43. B. Kepplinger, H. Baran, J. Newcombe, A. Kainz, D. Bibl and H. Nohl (2001) Kynurenic acid in CSF and serum of neuroinflammatory and neurodegenerative diseases. Neurochemistry Winter Conference March 17-22, 2001, Sölden, Austria. (Poster) 44. H. Baran (2001) Kynurenic acid metabolism and neurodegeneration: Significances in experimental and clinical studies. "Fortbildungsveranstaltung, NÖ Landesnervenklinik Mauer/Amstetten, Austria 2 März, 2001. (Lecture) 45. H. Baran, Biochemical and pharmacological studies of kynurenine metabolism (2001) Experimental and clinical significances. Hearing, Medizinische Fakultät der LeopoldFranzes-Universität Innsbruck 6 März, 2001. 46. H. Baran, Kepplinger B, Kainz A. (2001) Subcortical sclerotic encephalopathy is associated with increased KYNA in CSF. 9th Austian-Czech Symposium April, 21st 2001. (Lecture) 47. Kepplinger B., Baran H. (2001) Alkoholepilepsie. XII. Niederösterreichische Notärztetagung, 19-20 Mai 2001 Stift Göttweig, Österreich. (Lecture) 48. H. Baran, Kepplinger B., Kainz A., Nohl H., Schafelner D., Bibl D. (2001) Erhöhte Kynurensäure (KYNA)-Levels im Liquor cerebrospinalis von Patienten mit Polyneuropatie. 9. Jahrestagung der Österreichischen Schmerzgesellschaft 14.-17. Juni 2001 Velden/Wörthersee Klagenfurt, Austria. (Lecture) 49. H. Baran (2001) Differential susceptibility of Neurochemical markers upon kainate induced epilepsy and its significances 33rd International Danube Symposium for Neurological Sciences and Continuing Symposium for Neurological Sciences and Continuing Education 29 th August-1st September, 2001, Lublin, Poland (Lecture). 50. H. Baran, B. Kepplinger, C. Derfler, A. Kainz, J. Newcombe and H. Nohl (2001) Kynurenic acid in CSF and serum of Subcortical sclerotic encephalopathy. Soc. for Neuroscience November 10-15, San Diego, Calif. USA. (Poster). 51. B. Kepplinger, H. Baran, H. Schmid, J Wallner, J. Newcombe, and H. Nohl H. (2001) Increased kynurenic acid levels in the CNS of patients suffering from polyneuropathy and neuroborreliosis. Soc. for Neuroscience November 10-15, San Diego, Calif. USA. (Poster). 52. H. Baran, B. Kepplinger, J.A. Heinfelner, G. Lubec and H. Budka (2002) Kynurenic acid metabolism in different types of brain pathology in HIV-1 infected patients. 6th Congress of the European Federation of Neurological Societies, Vienna, October 26-29, 2002. (Lecture). 53. H. Baran, B. Kepplinger, G.Skofitsch, H. Lassmann (2002) Malignant glioma within the temporal lobe in the rat brain after kainic acid induced chronic epilepsy - 6th Congress of the European Federation of Neurological Societies, Vienna, October 26-29, 2002. (Poster). 54. M. Draxler and H. Baran (2003) Veränderungen der Cholinacetyltransferase Aktivität im Gehirn in EMCV infizierten jung Schweinen. Demonstration der Disserdationsarbeit (Teil I), Institut für Pharmakologie und Toxikologie, Mai, VM Universität Wien. (Lecture). 55. H. Baran, B. Kepplinger, A. Kainz, M. Draxler, H. Ferraz-Leite, J. Wallner, J. Newcombe, and H. Erhart. (2003) Kynurenine aminotransferases in human cerebrospinal fluid. Thirteenth Meeting of European Neurological Society, Instanbul, Turkey , June 14-18, 2003. (Lecture). 12 56. B. Kepplinger, H. Baran, A. Kainz, H. Schmid, J. Wallner, M. Draxler, H. Ferraz-Leite, J. Wallner (2003) Increased kynurenic acid and IgG in cerebrospinal fluid of patients with polyneuropathy. Thirteenth Meeting of European Neurological Society, Instanbul, Turkey , June 14-18, 2003 (Poster). 57. M. Draxler, H. Baran, H. Kalbacher, N. Nowotny, P. Schmidt, B. Kepplinger, A. Url, A. Strasser and M. Schuh. (2003) Veränderungen der Marker des cholinergen Systems im ZNS bei Encephalomyocarditis-virus infizierten Jungschweinen. 13. Symposium der Pharmakologie und Toxikologie, München, 25-26 September, 2003. (Lecture). 58. H. Baran, M. Draxler, H. Kalbacher, N. Nowotny, P. Schmidt, B. Kepplinger, A. Url, G. Hofecker and M. Schuh. (2003) Kynurenine metabolismus bei Encephalomyocarditisvirus infizierten Jungschweinen. 13. Symposium der Pharmakologie, München, 25-26 September, 2003 (Lecture). 59. B. Kepplinger D. Schafelner, H. Baran and P. Kalina (2003) Nerve root stimulation as a novel alternative to spinal cord stimulation in the treatment of chronic radicular pain in human. 33rd Annual Meeting, November, Society of Neuroscience, New Orleans, LA, USA (Lecture). 60. H. Baran, M. Draxler, H. Kalbacher, N. Nowotny, P. Schmidt, B. Kepplinger, A. Url, M. Schuh, G. Hofecker. (2003) Kynurenine aminotransferase I and II (KAT I and KAT II) in piglet’s brain after Encephalomyocarditis (EMCV) infection. 33rd Annual Meeting, Society of Neuroscience, November New Orleans, LA, USA (Poster). 61. M. Draxler, H. Baran, H. Kalbacher, N. Nowotny, P. Schmidt, B. Kepplinger, A. Url, A. Strasser and M. Schuh. (2003) Affected GABA- and cholinergic activities in the CNS after encephalomyocarditis (EMCV) virus infection. 13th Neuropharmacology Meeting, 5 Nov. 2003, New Orleans, LA, USA. . (Poster). 62. H. Baran, M. Draxler, B. Kepplinger, H. Kahlbacher, N. Nowotny, P. Schmidt, A. Url, M. Schuh and G. Hofecker (2003) Kynurenine metabolism in piglet brain due to EMCV infection. 9. Wissenschaftliche Symposium der Österreichischen Pharmakologischen Gesellschft. 21.-22.November 2003, Wien, Austria. (Lecture). 63. H. Baran, M. Draxler, B. Kepplinger (2004) Picornea encephalomyocarditis-evidences for neurochemical alterations. 12th Czech-Austrian Symposium on Medical Sciences and Art, April 16th –17th, 2004, Metropol Ceske Budejovice/Budweis, Czech Republic. (Lecture). 64. B. Kepplinger, H. Baran, H. Papst, H. Ferraz-Leite, J. Wallner and H. Schmid (2004) Kynurenate and its analogues: a new route for therapeutic applications. 7th Congress of the European Society for Clinical Neuropharmacology 5-9 May, 2004 Congress Trieste, Italy. (Poster). 65. H. Baran (2004) Kynurenic acid metabolism – pharmacological and clinical aspects. 7th Congress of the European Society for Clinical Neuropharmacology 5-9 May, 2004 Congress Trieste, Italy. (Lecture). 66. H. Baran (2004) Biochemische und Pharmacologische Aspekte bei der Depression – Tryptophan-metabolismus und Katecholamine, Bad Blumau, Austria, 5 Juni, 2004 (Lecture). 67. H. Baran, B. Kepplinger, A. Kainz, M. Draxler, E. Okuno, H. Ferraz-Leite, J. Wallner, J. Newcombe, E. Erhart (2004) Investigation of kynurenine aminotransfearses (KATs) in human cerebrospinal fluid (CSF) from normal human subjects and multiple sclerosis (MS) 13 patients. 14th Meeting of the European Neurological Society, Barcelona, June 26-30, Spain (Poster). 68. M. Draxler H. Baran, F. Schmoll, N. Nowotny, B. Kepplinger, A. Url, P. Schmidt, A. Strasser, H. Niedermüller, G. Hofecker and M. Schuh (2004) Affected choline acetyltransferase (ChAT) activity in piglet brain after encephalomyocarditis (EMCV) virus infection. IPVS 2004, 18th Congress of the International Pig Veterinary Society, June 27Juli1, 2004, Congress Centrum Hamburg, Germany. (Lecture). 69. M. Draxler, B. Kepplinger, F. Schmoll, N. Nowotny, A. Url, P. Schmidt, A. Strasser, H. Niedermüller, M. Schuh and H. Baran (2004) Choline acetyl transferase (ChAT) and glutamic acid decarboxylase (GAD) activities in control piglet brain. IPVS 2004, 18th Congress of the International Pig Veterinary Society, June 27-Juli1, 2004- Congress Centrum Hamburg, Germany. (Poster). 70. H. Baran, B. Kepplinger, Ch. Lang, M. Draxler, F. Schmoll, A. Strasser, M. Schuh and N. Nowotny (2004) Enhancement of kynurenic acid (KYNA) and neopterin levels in serum of piglets after encephalomyocarditis virus (EMCV) infection. IPVS 2004, 18th Congress of the International Pig Veterinary Society, June 27-Juli1, 2004-Congress Centrum Hamburg, Germany. (Poster). 71. H. Baran, M. Draxler, B. Kepplinger and H. Niedermüller (2004) Reduced glutamic acid decarboxylase (GAD) brain regions of piglets in experimental encephalomyocarditis (EMCV) model. 8th Congress of the European Federation of Neurological Societies, Paris, September 4-7, 2004, France. (Poster). 72. B. Kepplinger, M. Draxler, A. Strasser and H. Baran (2004) Choline acetyltransferase activity in the spinal cord after experimental encephalomyocarditis virus (EMCV) infection. 8th Congress of the European Federation of Neurological Societies, Paris, September 4-7, 2004, France. (Poster). 73. H. Baran, B. Kepplinger, M. Draxler and H. Ferraz-Leite (2004) Investigation of glutamatergic and GABAergic activities in experimental epilepsy. 2 nd International Congress on Neuroregeneration, Rio De Janeiro, September 20-24, 2004, Brazil. (Lecture). 74. H. Baran (2005) Alterations of taurine in the brain of chronic kainic acid epilepsy model. 9th International Congress on Amino Acids and Proteins, August 8-12, Vienna, Austria. (Lecture). 75. H. Baran, B Kepplinger (2005) Glycine in the brain of chronic kainic acid epilepsy model. 9th Congress of the European Federation of Neurological Societies, 17-20 September, 2005, Athens, Greece. (Poster). 14